Health & Pharmaceutical Outcomes (MS) Program Track

This program track trains the student to critically analyze the impact and outcomes of pharmaceutical products and services within health care systems.

This program is also offered as a PhD degree in pharmaceutical sciences with an emphasis in health and pharmaceutical outcomes.


View Health and Pharmaceutical Outcomes 2021-2022 Handbook



Master of Science (MS) Program

The goal of the MS program is to provide the student with the essential skills and abilities to assume managerial and leadership positions related to the economic analysis, outcomes of pharmaceuticals, pharmaceutical services and health care in health care organizations, government agencies, pharmaceutical companies and academic institutions.

Academic Environment 

The College of Pharmacy's Center for Health Outcomes and PharmacoEconomic Research (HOPE) was created to assist medical care researchers, providers, payers, regulators and manufacturers in documenting the relative value of pharmaceutical products and services. The center conducts research and trains graduate students in areas such as cost-benefit/cost-effectiveness analysis, comparative effectiveness research, patient safety and quality improvement research, health disparities analysis, drug-drug interaction analysis, health technology assessment, meta-analysis, quality-of-life assessment, disease management and drug use evaluation.

The University of Arizona has strong supporting programs in management and policy, epidemiology, economics and educational psychology. The University of Arizona Health Sciences includes colleges of medicine, public health and nursing and the resources of a major teaching hospital complex.


MS students are self-pay (no funding is available from the Program.)


 Apply at UA Graduate Admissions Application



Terri Warholak, PhD, RPH
Designate Assitant Dean, Academic Affairs/Assessment
Professor, Pharmacy Practice & Science
Assistant Professor, Public Health
Drachman Hall B307D